eloralintide vs retatrutide Tirzepatide Compared Eloralintide Phase 2 Topline results

Retatrutide is projected to receive FDA approval in late 2027 or 2028

Hair loss has not been formally confirmed as a direct adverse effect of retatrutide in published trial data, but rapid weight loss associated with the drug may trigger telogen effluvium, a temporary shedding condition

The Gila monsters venomous saliva contains a molecule called exendin-4 that extends insulin production by mimicking a natural hormone, enabling efficient sugar processing after large meals

Online clinics like Shed offer access to prescription medications such as Wegovy and Zepbound

The FDA has approved two prescription medications containing tirzepatide: Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes mellitus, and Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight who have weight-related medical problems